Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Report extract r.e methanol market:
https://www.benzinga.com/pressreleases/21/12/g24626158/methanol-market-to-surpass-us-38-901-million-by-2028-cagr-4-report-by-acumen-research-and-consulti
Press release indicates we will manufacture and and distribute in AUS but not much else besides.
Seems there's another distributor elsewhere:
https://www.yahoo.com/now/onassis-launches-sales-top-line-173000870.html
Odd that Cimetra is listed under their products too.
I wouldn't say it is an irrelevance. Considering changing attitudes and perceptions of both the populace and the govt. The UK is (unsurprisingly a poor example) there have been what 3 prescriptions for cannabis based medicines in three years and seemingly no appetite to improve this:
https://www.mjinvest.com/news/uk-government-fails-to-back-new-measures-to-boost-medical-cannabis-access
Here it is class B and used as a Tory ploy in the same way as republicans in the US.
Whereas in Germany there are thousands of prescriptions issued per year and they are on the cusp of legalization.
https://www.google.com/amp/s/www.benzinga.com/amp/content/24574979
Pfizer buyout of Arena Pharmaceuticals for $6.7B, seems a lot of similar products in their pipeline as here. Pie in the sky in know but...
I meant over and above the inclusion of CBD for other ailments/treatments, KNB vape incorporates THC. Also just seen:
https://www.theguardian.com/society/2021/dec/13/malta-to-be-first-in-europe-to-legalise-cannabis-for-personal-use?s=09
https://www.transparencymarketresearch.com/cannabis-vaporizers-market.html
Any ideas as to whether there is an intention to move into recreational consumer market? Also any plans to use as therapeutic device, not just CBD as KNB have approval in Israel?
I didn't feel obliged to provide a transcript of the video hence the link. I highlighted the bold claims he made, and I stress claims. I am under no illusions as far as Roby is concerned. Also the reason I noted *still* awaiting news on India emergency approval.
I was also pondering the cessation of trials for merk & and pzifer treatments due to their efficacy. No such actions as far as Cimetra is concerned, do we deduce that is as a result of lower effectiveness or simply the company being less established or potentially cronyism?
https://www.***************************/ibstock-plc-17.0-potential-upside-indicated-by-jp-morgan/4121037690
JP Morgan stating on current value should be 17% upside.
Just checking I see that no one has yet reviewed their purchase on trustpilot. Thoughts as to whether we ought to in order to give confidence to potential buyers of the product that are not invested and unsure of its efficacy/authenticity?
https://youtu.be/xrkWWiqIYDE
Roby on proactive interview. Indicating when Malta facility is operational he believes the 20,000 units a day production capacity would be insufficient to meet demand and other facility usage has been sourced to meet demand. Here's hoping this is an accurate prediction as we still await news r.e Indian approval.
And the window opportunity closes yet further...
https://www.bbc.co.uk/news/health-59178291